. 2018 Mar 25;6(2):168–174. doi: 10.14218/JCTH.2017.00050
© 2018 Authors.
This article has been published under the terms of Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0), which permits noncommercial unrestricted use, distribution, and reproduction in any medium, provided that the following statement is provided. “This article has been published in Journal of Clinical and Translational Hepatology at DOI: 10.14218/JCTH.2017.00050 and can also be viewed on the Journal’s website at http://www.jcthnet.com”.
Fig. 1. Site of action of anti-diabetic medications in NASH/NAFLD.
